Josiah Craver's most recent trade in Sensei Biotherapeutics Inc was a trade of 30,824 Performance-Based Stock Option (right to buy) done . Disclosure was reported to the exchange on July 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sensei Biotherapeutics Inc | Josiah Craver | PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2026 | 30,824 | 30,824 | - | - | Performance-Based Stock Option (right to buy) | |
| Sensei Biotherapeutics Inc | Josiah Craver | PFO & PAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2026 | 80,000 | 80,000 | - | - | Stock Option (right to buy) | |
| Sensei Biotherapeutics Inc | Josiah Craver | Principal Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sensei Biotherapeutics Inc | Craver Josiah | Principal Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) |